Clinical Trial Update: Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery [NA]

View source ↗

Summary

A clinical trial evaluating gemcitabine, capecitabine, and bevacizumab for pancreatic cancer that can be removed by surgery has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Capecitabine (capecitabine)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Pancreatic Cancer | NA | Status: WITHDRAWN